MRK

Merck & Co., Inc.

MRK · CIK 310158 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$65.0B
20182025
Net Income$18.3B
20182025
Operating CF$16.5B
20182025
Free Cash Flow$12.4B
20182025

Income Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Revenue$65.0B$64.2B$60.1B$59.3B$48.7B$48.0B$46.8B$42.3B
Cost of Revenue$16.4B$15.2B$16.1B$17.4B$13.6B$15.5B$14.1B$13.5B
Gross Profit
R&D Expense$15.8B$17.9B$30.5B$13.5B$12.2B$13.6B$9.9B$9.8B
SG&A Expense$10.7B$10.8B$10.5B$10.0B$9.6B$10.5B$10.6B$10.1B
Operating Income
Net Income$18.3B$17.1B$0.4B$14.5B$13.0B$7.1B$9.8B$6.2B
EPS (Basic)$7.30$6.76$0.14$5.73$5.16$2.79$3.84$2.34
EPS (Diluted)$7.28$6.74$0.14$5.71$5.14$2.78$3.81$2.32

Balance Sheet

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Total Assets$136.9B$117.1B$106.7B$109.2B$105.7B$91.6B$84.4B$82.6B
Current Assets$43.5B$38.8B$32.2B$35.7B$30.3B$27.8B$27.5B$25.9B
Cash & Equivalents$14.6B$13.2B$6.8B$12.7B$8.1B$8.1B$9.7B$8.0B
Total Liabilities
Current Liabilities$28.3B$28.4B$25.7B$24.2B$23.9B$27.3B$22.2B$22.2B
Stockholders' Equity$52.6B$46.3B$37.6B$46.0B$38.2B$25.3B$25.9B$26.7B

Cash Flow Statement

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Operating Cash Flow$16.5B$21.5B$10.3B$13.4B$10.9B
Investing Cash Flow$-13.7B$-7.7B$-9.4B$-2.6B$4.3B
Capital Expenditures$4.1B$3.4B$3.9B
Financing Cash Flow$-1.9B$-7.0B$-2.8B$-8.9B$-13.2B